Nppc/Npr2/cGMP signaling cascade maintains oocyte developmental capacity

Area of Science:

• Reproductive Biology
• Developmental Biology
• Endocrinology

Background:

• Follicle survival requires specific criteria from embryonic life to the luteinizing hormone (LH) peak.
• The natriuretic peptide precursor type C (Nppc) and natriuretic peptide receptor 2 (Npr2) system is vital for female fertility.
• This pathway influences oocyte developmental capacity and maintains meiotic arrest.

Purpose of the Study:

• To review the role of the Nppc/Npr2/cGMP signaling pathway in maintaining oocyte meiotic arrest.
• To explore the pathway's contribution to producing oocytes with developmental capacity.
• To discuss the potential therapeutic use of agonists/antagonists for oocyte maturation.

Main Methods:

• Literature review of recent experimental evidence on Nppc/Npr2/cGMP signaling.
• Analysis of the pathway's impact on ovarian and uterine development.
• Examination of consequences of defective Nppc/Npr2 signaling on oocyte and follicle quality.

Main Results:

• Nppc/Npr2 signaling increases intracellular cyclic guanosine monophosphate (cGMP), essential for ovarian and uterine development.
• Defects in this pathway result in small ovaries, underdeveloped uterine horns, thin endometrium/myometrium, and disorganized chromosomes.
• Impaired signaling leads to abnormal cumulus expansion, premature meiotic resumption, and reduced oocyte quantity and quality.

Conclusions:

• The Nppc/Npr2/cGMP pathway is indispensable for maintaining oocyte meiotic arrest and ensuring the production of developmentally competent oocytes.
• Dysfunctional signaling severely impacts female reproductive health and oocyte quality.
• Investigating agonists and antagonists of this pathway may offer new strategies for triggering oocyte maturation.